Tele-Exercise for Male Elite Fencers

NCT05864651 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-07-24

No results posted yet for this study

Summary

Tele-exercise has been used to enhance athletic performance among athletes. Physical performance indicators such as lunge distance, speed, reaction time, coordination, and balance control during stationary jumps can be used to measure the effectiveness of tele-exercise programs for fencing athletes.

The objective of this study was to examine the effectiveness of tele-exercise programs on lunge distance, speed, reaction time, coordination, and balance control during stationary jumps among male elite fencers.

Conditions

  • Sports Physical Therapy
  • Athletic Performance

Interventions

OTHER

Tele-exercise program

The tele-exercise program focused on lunge movement with additional strengthening abdominal and lumbopelvic muscle training while maintaining neuromuscular control. The difficulty of training was adjusted every week according to the five-step mastery program

OTHER

Conventional Fencing Exercise

The conventional exercise was based on 'displacement', a basic footwork training in fencing. The Displacement is also basic footwork to approach the opponent. The Displacement consisted of seven movements including 'Marche', 'Retraite \& Rompre', 'Passe avant', 'Passe arrière', 'Bond en avant', 'Bond en arrière', and 'Balestra'.

Sponsors & Collaborators

  • Sahmyook University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-22
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05864651 on ClinicalTrials.gov